Tapewire

Nasdaq · USD

IRWD

IRONWOOD PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
5213
SEC CIK
0001446847
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026012
Mar 202602
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2017 Filed Feb 24, 2017 16:36 UTC
MCCOURT Thomas AChief Commercial Officer
SaleClass A Common Stock 1,520 $16.94 $25,748.80
Disclosure

SEC source: 0001209191-17-014367 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,050

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: The reporting person acquired 2,258 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2016.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:38 UTC
Currie Mark GChief Scientific Officer
SaleClass A Common Stock 1,800 $16.94 $30,492.00
Disclosure

SEC source: 0001209191-17-014374 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,258

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:35 UTC
Gilbert Halley EChief Legal Officer
SaleClass A Common Stock 2,674 $16.94 $45,297.56
Disclosure

SEC source: 0001209191-17-014361 · doc4.xml · nonDerivative · entry 2

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,807

F3 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:35 UTC
Gilbert Halley EChief Legal Officer
SaleClass A Common Stock 2,365 $16.94 $40,063.10
Disclosure

SEC source: 0001209191-17-014361 · doc4.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,481

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:34 UTC
Consylman GinaChief Accounting Officer
SaleClass A Common Stock 1,431 $16.94 $24,241.14
Disclosure

SEC source: 0001209191-17-014354 · doc4.xml · nonDerivative · entry 2

Consylman Gina · CIK 0001546358 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,784

F3 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:34 UTC
Consylman GinaChief Accounting Officer
SaleClass A Common Stock 408 $16.94 $6,911.52
Disclosure

SEC source: 0001209191-17-014354 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,215

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 14, 2017 Filed Feb 15, 2017 23:12 UTC
Gilbert Halley EChief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 37,385 $3.76 Strike: $3.76 $140,567.60
Disclosure

SEC source: 0001209191-17-011203 · doc4.xml · derivative · entry 4

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 37,385 shares

Expires 2018-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares of Class B Common Stock on the first anniversary of February 1, 2008, and 1/48th of the shares of Class B Common Stock vested each month thereafter for the next 36 months. The option was fully vested as of February 1, 2012.

Read SEC document
February 14, 2017 Filed Feb 15, 2017 23:12 UTC
Gilbert Halley EChief Legal Officer
SaleClass B Common Stock 37,385 $16.75 $626,198.75
Disclosure

SEC source: 0001209191-17-011203 · doc4.xml · nonDerivative · entry 2

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.

Read SEC document
February 14, 2017 Filed Feb 15, 2017 23:12 UTC
Gilbert Halley EChief Legal Officer
Exercise / conversionClass B Common Stock 37,385 $3.76 $140,567.60
Disclosure

SEC source: 0001209191-17-011203 · doc4.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 18, 2017 Filed Jan 20, 2017 22:57 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 55,987 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001209191-17-004975 · doc4.xml · derivative · entry 3

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 55,987 shares

Expires 2017-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2011.

Read SEC document
January 18, 2017 Filed Jan 20, 2017 22:57 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionClass B Common Stock 55,987 $2.94 $164,601.78
Disclosure

SEC source: 0001209191-17-004975 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 775,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 12, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 32,994 $2.94 Strike: $2.94 $97,002.36
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · derivative · entry 9

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 32,994 shares

Expires 2017-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2011.

Read SEC document
January 12, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
SaleClass B Common Stock 32,994 $15.50 $511,407.00
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · nonDerivative · entry 4

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,670,322

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $15.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 12, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
Exercise / conversionClass B Common Stock 32,994 $2.94 $97,002.36
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · nonDerivative · entry 3

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,703,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 32,993 $2.94 Strike: $2.94 $96,999.42
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · derivative · entry 8

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,994

Underlying: Class B Common Stock · 32,993 shares

Expires 2017-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2011.

Read SEC document
January 11, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
SaleClass B Common Stock 32,993 $15.84 $522,609.12
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · nonDerivative · entry 2

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,670,322

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 11, 2017 Filed Jan 13, 2017 21:37 UTC
Hecht Peter MDirector · Chief Executive Officer
Exercise / conversionClass B Common Stock 32,993 $2.94 $96,999.42
Disclosure

SEC source: 0001209191-17-003679 · doc4.xml · nonDerivative · entry 1

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,703,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2017 Filed Jan 10, 2017 22:31 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 34,013 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001209191-17-003240 · doc4.xml · derivative · entry 3

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,987

Underlying: Class B Common Stock · 34,013 shares

Expires 2017-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock each monthly anniversary thereafter. The option was fully vested as of January 1, 2011.

Read SEC document
January 06, 2017 Filed Jan 10, 2017 22:31 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionClass B Common Stock 34,013 $2.94 $99,998.22
Disclosure

SEC source: 0001209191-17-003240 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 719,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 01, 2017 Filed Jan 4, 2017 22:08 UTC GrantClass A Common Stock 9,793 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-001151 · doc4.xml · nonDerivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,793

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
December 16, 2016 Filed Dec 20, 2016 22:40 UTC
Consylman GinaChief Accounting Officer
GrantClass A Common Stock 10,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-156155 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,623

F1 · kind: The restricted stock unit award vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 22:35 UTC GrantClass A Common Stock 161 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-155978 · doc4.xml · nonDerivative · entry 1

MCGUIRE TERRANCE · CIK 0001117003 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,414

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 17:39 UTC GrantClass A Common Stock 161 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-155979 · doc4.xml · nonDerivative · entry 1

WALSH CHRISTOPHER T PHD · CIK 0001120360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,357

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:04 UTC
Currie Mark GChief Scientific Officer
GiftClass A Common Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-154198 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,058

Read SEC document
December 05, 2016 Filed Dec 7, 2016 23:57 UTC SaleClass A Common Stock 3,200 $15.68 $50,176.00
Disclosure

SEC source: 0001209191-16-154010 · doc4.xml · nonDerivative · entry 1

OLANOFF LAWRENCE S · CIK 0001224341 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,105

F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 11, 2016 Filed Nov 15, 2016 22:11 UTC
Gilbert Halley EChief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,000 $3.76 Strike: $3.76 $52,640.00
Disclosure

SEC source: 0001209191-16-150218 · doc4.xml · derivative · entry 4

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 14,000 shares

Expires 2018-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested upon the earlier of (i) the issuer's achievement of a regulatory milestone and (ii) February 1, 2014. The regulatory milestone was met, so the option was fully vested as of October 24, 2011.

Read SEC document
November 11, 2016 Filed Nov 15, 2016 22:11 UTC
Gilbert Halley EChief Legal Officer
SaleClass B Common Stock 14,000 $16.75 $234,500.00
Disclosure

SEC source: 0001209191-16-150218 · doc4.xml · nonDerivative · entry 2

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.

Read SEC document
November 11, 2016 Filed Nov 15, 2016 22:11 UTC
Gilbert Halley EChief Legal Officer
Exercise / conversionClass B Common Stock 14,000 $3.76 $52,640.00
Disclosure

SEC source: 0001209191-16-150218 · doc4.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 22:16 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 300,000 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001209191-16-147712 · doc4.xml · derivative · entry 3

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 300,000 shares

Expires 2017-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On October 31, 2016, the reporting person exercised the option pursuant to an early exercise provision. The right to acquire the shares will vest upon the earlier of (i) the Issuer's achievement of certain clinical, regulatory and market capitalization milestones and (ii) January 22, 2017.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 22:16 UTC
Currie Mark GChief Scientific Officer
Exercise / conversionClass B Common Stock 300,000 $2.94 $882,000.00
Disclosure

SEC source: 0001209191-16-147712 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 685,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The right to acquire the shares will vest upon the earlier of (i) the Issuer's achievement of certain clinical, regulatory and market capitalization milestones and (ii) January 22, 2017.

Read SEC document
September 15, 2016 Filed Sep 19, 2016 20:43 UTC GrantClass A Common Stock 166 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-141990 · doc4.xml · nonDerivative · entry 1

MCGUIRE TERRANCE · CIK 0001117003 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,253

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
September 15, 2016 Filed Sep 19, 2016 16:42 UTC GrantClass A Common Stock 166 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-141989 · doc4.xml · nonDerivative · entry 1

WALSH CHRISTOPHER T PHD · CIK 0001120360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,196

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
September 06, 2016 Filed Sep 7, 2016 23:06 UTC SaleClass A Common Stock 3,200 $13.72 $43,904.00
Disclosure

SEC source: 0001209191-16-140466 · doc4.xml · nonDerivative · entry 1

OLANOFF LAWRENCE S · CIK 0001224341 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,305

F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.49 to $13.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.